Oral effectiveness of PMIC4, a novel hydroxyethylpiperazine analogue, in Leishmania amazonensis.
Authors: Vasconcelos, M.F.; Cunha Jr.; E.F.; Andrade Neto, V.V.; Siqueira, L.M.; D’avila-Levy, C.M.; Moreth, M.; Cunico, W.; De Souza, M.V.N.; Gomes, C.R.B.; Torres-Santos, E.C. Source: Journal for Parasitology: Drugs and Drug Resistance, v. 4, p. 210-213, 2014. Publisher: Elsevier Abstract Pentavalent antimonials have saved the lives of thousands of Leishmania-infected patients more than seventy years but, […]
